T1	Participants 79 146	children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease:
T2	Participants 366 524	pediatric and adolescent patients with Hodgkin disease. Children < or =21 years old with biopsy-proven, pathologically staged I, IIA, or IIIA1 Hodgkin disease